Valuation: Terumo Corporation

Market Cap 3,345B 20.6B 18B 16.61B 15.31B 28.86B 1,984B 29.5B 199B 78.1B 972B 77.36B 75.67B P/E 2027 *
20x
P/E 2028 * 18x
Enterprise Value 3,420B 21.07B 18.41B 16.99B 15.66B 29.51B 2,029B 30.17B 203B 79.87B 994B 79.12B 77.38B EV / Sales 2027 *
2.76x
EV / Sales 2028 * 2.55x
Free-Float
97.07%
Yield 2027 *
1.57%
Yield 2028 * 1.76%
1 day+0.54%
1 week+3.05%
Current month+2.67%
1 month+1.04%
3 months+1.19%
6 months+4.66%
Current year-3.21%
1 week 13.37
Extreme 13.37
14.14
1 month 13.07
Extreme 13.07
14.34
Current year 12.08
Extreme 12.08
15.67
1 year 12.08
Extreme 12.08
19.6
3 years 12.08
Extreme 12.08
21.22
5 years 12.08
Extreme 12.08
25.26
10 years 8.48
Extreme 8.475
25.26
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+3.05% - - 20.6B
+0.44%+9.84%-18.69%-9.53% 175B
+0.23%-0.29%-7.10%-6.74% 106B
-1.39%-0.42%+4.16%+57.62% 59.91B
+0.66%+0.96%+37.64%+54.22% 51.95B
-1.74%+1.21%-11.20%-40.89% 43.58B
-1.47%-2.85% - - 33.65B
-0.40%+0.08%-9.07%-41.52% 29.58B
-0.37%-0.82%+69.82%-5.81% 25.31B
-0.96%-0.49%-3.00%-6.16% 21.23B
Average -0.43%+1.58%+7.82%+0.15% 60.79B
Weighted average by Cap. -0.17%+2.75%-1.72%+1.15%

Financials

2027 *2028 *
Net sales 1,239B 7.63B 6.67B 6.15B 5.67B 10.69B 735B 10.92B 73.52B 28.92B 360B 28.65B 28.02B 1,317B 8.11B 7.09B 6.54B 6.03B 11.37B 781B 11.62B 78.2B 30.76B 383B 30.47B 29.8B
Net income 166B 1.02B 892M 823M 759M 1.43B 98.31B 1.46B 9.84B 3.87B 48.15B 3.83B 3.75B 185B 1.14B 998M 921M 849M 1.6B 110B 1.64B 11.01B 4.33B 53.87B 4.29B 4.2B
Net Debt 75.69B 466M 407M 376M 347M 653M 44.89B 668M 4.49B 1.77B 21.99B 1.75B 1.71B 14.29B 88.01M 76.92M 70.98M 65.42M 123M 8.48B 126M 848M 334M 4.15B 331M 323M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
26-07-20 US$14.04 +0.54% 2,251
26-07-17 US$13.96 +2.80% 145,970
26-07-16 US$13.58 +1.12% 149,052
26-07-15 US$13.43 -2.68% 110,515
26-07-14 US$13.80 +1.32% 343,578
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,267.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+30.61%

Quarterly revenue - Rate of surprise